NewsRx

Search our medical news database

Prevention (HAV)

Reviews Mixed for Hepatitis A Vaccination Programs

Published in Medical Letter on the CDC and FDA, August 11th, 1997

The reviews are mixed for ongoing hepatitis A virus vaccination programs aimed at high risk groups within the United States. While some such programs report high rates of vaccination, others are failing to reach their targeted population.

"The effectiveness of these programs in reaching the targeted population has varied," researchers from the U.S. Centers for Disease Control and Prevention (CDC) wrote in a recent report ("Hepatitis A Vaccine Programs in Communities with High Rates of Hepatitis A," Morbidity and Mortality Weekly Report, July 4,1997;601-603). "The high proportion of unvaccinated children surveyed who had visited a facility during the preceding year...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook